- Home
- RRBI vs MREO Comparison
RRBI vs MREO Comparison
Compare RRBI & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- MREO
- Stock Information
- Founded
- RRBI 1998
- MREO 2015
- Country
- RRBI United States
- MREO United Kingdom
- Employees
- RRBI N/A
- MREO N/A
- Industry
- RRBI Hotels/Resorts
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- RRBI Consumer Discretionary
- MREO Health Care
- Exchange
- RRBI Nasdaq
- MREO Nasdaq
- Market Cap
- RRBI 377.0M
- MREO 424.5M
- IPO Year
- RRBI 2019
- MREO N/A
- Fundamental
- Price
- RRBI $56.18
- MREO $2.42
- Analyst Decision
- RRBI Buy
- MREO Strong Buy
- Analyst Count
- RRBI 1
- MREO 7
- Target Price
- RRBI $62.00
- MREO $7.71
- AVG Volume (30 Days)
- RRBI 8.5K
- MREO 943.2K
- Earning Date
- RRBI 07-25-2025
- MREO 05-13-2025
- Dividend Yield
- RRBI 0.85%
- MREO N/A
- EPS Growth
- RRBI 13.23
- MREO N/A
- EPS
- RRBI 5.31
- MREO N/A
- Revenue
- RRBI $112,266,000.00
- MREO N/A
- Revenue This Year
- RRBI $4.69
- MREO N/A
- Revenue Next Year
- RRBI $5.73
- MREO $54.91
- P/E Ratio
- RRBI $10.56
- MREO N/A
- Revenue Growth
- RRBI 6.50
- MREO N/A
- 52 Week Low
- RRBI $42.78
- MREO $1.58
- 52 Week High
- RRBI $62.13
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- RRBI 57.43
- MREO 43.17
- Support Level
- RRBI $55.65
- MREO $2.11
- Resistance Level
- RRBI $56.83
- MREO $2.27
- Average True Range (ATR)
- RRBI 1.23
- MREO 0.13
- MACD
- RRBI -0.09
- MREO -0.02
- Stochastic Oscillator
- RRBI 53.43
- MREO 16.41
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).